Shilpa Medicare, 530549, SHILPAMED Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

16,862.09
56.71
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17,474.88
0.07%
6.28

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.04
6.08
10.15

EBITDA CAGR (%)

10 Years
5 Years
3 Years

8.95
14.07
10.09

PAT CAGR (%)

10 Years
5 Years
3 Years

8.51
32.03
96.89

P:E (Median)

8 Years
5 Years
3 Years

40.93
71.94
61.64

P:BV (Average)

8 Years
5 Years
3 Years

2.53
2.52
2.92

EV:EBITDA (Average)

8 Years
5 Years
3 Years

21.48
24.24
24.39

Earnings Forecasts:

(Updated: 22-08-2026)

Description 2026 2027 2028 2029
Adj EPS 75 12 - -
P/E Ratio 11.49 71.80 - -
Revenue 44.84 32.3 - 1536.2
EBITDA 1800.27 2130.33 - 444.2
Net Income 541.47 677.83 - 218
ROA 262.17 364.4 - -
P/B Ratio - - - 6.52
ROE 4.08 3.64 - 8
FCFF 9.47 11.87 - -
FCFF Yield 30.02 117.65 - -
Net Debt 0.24 0.95 - -
BVPS - - - 132.2

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 189.04 93.46 102.27% 201.11 126.21 59.35% 165.70 125.39 32.15% 134.93 129.68 4.05%
Expenses 133.03 73.62 80.70% 141.32 88.19 60.24% 134.70 102.92 30.88% 95.79 86.88 10.26%
EBITDA 56.01 19.84 182.31% 59.79 38.02 57.26% 31.01 22.47 38.01% 39.14 42.80 -8.55%
EBIDTM 29.63% 21.23% 29.73% 30.12% 18.71% 17.92% 29.01% 33.00%
Other Income 9.56 13.02 -26.57% 6.89 10.64 -35.24% 11.29 16.26 -30.57% 16.94 20.85 -18.75%
Interest 2.53 2.23 13.45% 2.62 1.91 37.17% 2.74 1.19 130.25% 2.44 1.01 141.58%
Depreciation 15.49 13.06 18.61% 14.41 12.34 16.77% 13.56 12.20 11.15% 13.15 12.02 9.40%
PBT 51.06 12.39 312.11% 78.02 -9.91 - 23.79 24.86 -4.30% 38.92 50.15 -22.39%
Tax -13.86 -6.32 - 7.06 -4.28 - 7.85 9.21 -14.77% 8.10 20.16 -59.82%
PAT 64.92 18.71 246.98% 70.96 -5.63 - 15.93 15.65 1.79% 30.83 29.99 2.80%
PATM 34.34% 20.02% 35.28% -4.46% 9.62% 12.48% 22.85% 23.13%
EPS 3.32 0.96 245.83% 3.63 -0.29 - 0.81 0.80 1.25% 1.58 1.53 3.27%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 465.78 321.47 44.89% 436.99 330.82 32.09% 409.73 319.30 28.32% 369.97 343.80 7.61%
Expenses 329.52 229.84 43.37% 317.28 251.62 26.09% 295.43 238.66 23.79% 261.69 257.79 1.51%
EBITDA 136.26 91.63 48.71% 119.71 79.20 51.15% 114.30 80.65 41.72% 108.28 86.00 25.91%
EBIDTM 29.25% 28.50% 27.39% 23.94% 27.90% 25.26% 29.27% 25.02%
Other Income 3.13 6.38 -50.94% 1.67 7.63 -78.11% 0.81 1.18 -31.36% 1.75 4.99 -64.93%
Interest 12.10 18.78 -35.57% 13.66 14.49 -5.73% 10.68 11.75 -9.11% 15.67 25.55 -38.67%
Depreciation 35.20 28.92 21.72% 30.62 28.79 6.36% 30.36 28.81 5.38% 29.82 28.28 5.45%
PBT 92.09 50.31 83.05% 102.12 12.97 687.36% 61.21 41.27 48.32% 64.54 37.16 73.68%
Tax -2.83 2.70 - 12.65 0.76 1,564.47% 16.27 9.83 65.51% 20.36 18.83 8.13%
PAT 94.92 47.61 99.37% 89.47 12.21 632.76% 44.94 31.44 42.94% 44.18 18.33 141.03%
PATM 20.38% 14.81% 20.47% 3.69% 10.97% 9.85% 11.94% 5.33%
EPS 5.16 2.40 115.00% 5.51 0.74 644.59% 2.28 1.63 39.88% 2.25 0.92 144.57%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 690.78 597.03 477.40 309.79 247.70 356.95 257.05 805.97 663.88 741.29 733.67 Net Sales Growth 45.51% 25.06% 54.10% 25.07% -30.61% 38.86% -68.11% 21.40% -10.44% 1.04% Cost Of Goods Sold 247.71 211.92 110.79 79.41 73.26 67.61 50.87 258.38 229.62 348.45 365.75 Gross Profit 443.07 385.11 366.61 230.38 174.44 289.34 206.19 547.60 434.26 392.85 367.92 GP Margin 64.14% 64.50% 76.79% 74.37% 70.42% 81.06% 80.21% 67.94% 65.41% 53.00% 50.15% Total Expenditure 504.84 482.97 350.53 288.31 302.88 345.93 228.58 568.18 476.96 573.43 560.97 Power & Fuel Cost - 18.93 17.89 18.73 18.70 17.47 12.42 35.31 31.39 27.00 24.56 % Of Sales - 3.17% 3.75% 6.05% 7.55% 4.89% 4.83% 4.38% 4.73% 3.64% 3.35% Employee Cost - 110.99 89.95 103.64 109.54 110.57 76.10 149.28 124.66 113.29 91.53 % Of Sales - 18.59% 18.84% 33.45% 44.22% 30.98% 29.61% 18.52% 18.78% 15.28% 12.48% Manufacturing Exp. - 53.04 67.70 35.81 49.01 69.46 42.87 75.34 55.63 55.48 50.58 % Of Sales - 8.88% 14.18% 11.56% 19.79% 19.46% 16.68% 9.35% 8.38% 7.48% 6.89% General & Admin Exp. - 56.19 41.47 32.03 32.09 55.13 27.74 24.76 16.55 12.15 11.52 % Of Sales - 9.41% 8.69% 10.34% 12.96% 15.44% 10.79% 3.07% 2.49% 1.64% 1.57% Selling & Distn. Exp. - 19.84 12.37 7.07 6.15 15.59 10.25 10.04 6.51 6.00 4.51 % Of Sales - 3.32% 2.59% 2.28% 2.48% 4.37% 3.99% 1.25% 0.98% 0.81% 0.61% Miscellaneous Exp. - 12.06 10.36 11.63 14.13 10.09 8.33 15.07 12.61 11.06 4.51 % Of Sales - 2.02% 2.17% 3.75% 5.70% 2.83% 3.24% 1.87% 1.90% 1.49% 1.71% EBITDA 185.95 114.06 126.87 21.48 -55.18 11.02 28.47 237.79 186.92 167.86 172.70 EBITDA Margin 26.92% 19.10% 26.58% 6.93% -22.28% 3.09% 11.08% 29.50% 28.16% 22.64% 23.54% Other Income 44.68 79.80 78.93 93.94 79.82 51.52 37.14 18.37 17.16 34.52 29.82 Interest 10.33 10.04 5.87 17.26 20.83 9.05 6.07 4.33 2.79 2.12 2.79 Depreciation 56.61 55.11 48.86 49.61 46.55 34.82 22.28 34.96 34.01 32.78 26.66 PBT 191.79 128.71 151.07 48.54 -42.73 18.68 37.26 216.88 167.27 167.49 173.08 Tax 9.15 15.15 37.43 11.15 -8.79 7.33 25.12 44.15 37.75 34.25 41.09 Tax Rate 4.77% 10.23% 35.54% 29.27% 15.08% 26.66% 27.85% 20.79% 21.76% 20.45% 24.38% PAT 182.64 132.98 67.90 26.94 -49.48 20.16 65.09 168.19 135.75 133.24 127.45 PAT before Minority Interest 182.64 132.98 67.90 26.94 -49.48 20.16 65.09 168.19 135.75 133.24 127.45 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 26.44% 22.27% 14.22% 8.70% -19.98% 5.65% 25.32% 20.87% 20.45% 17.97% 17.37% PAT Growth 211.04% 95.85% 152.04% - - -69.03% -61.30% 23.90% 1.88% 4.54% EPS 9.34 6.80 3.47 1.38 -2.53 1.03 3.33 8.60 6.94 6.81 6.52

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,682.47 1,538.87 1,286.43 1,151.60 1,050.11 1,145.52 901.13 907.91 733.39 788.83 779.16 Net Sales Growth 27.91% 19.62% 11.71% 9.66% -8.33% 27.12% -0.75% 23.80% -7.03% 1.24% Cost Of Goods Sold 515.96 442.86 397.37 394.23 416.04 383.22 270.73 277.73 257.03 355.87 371.81 Gross Profit 1,166.51 1,096.01 889.06 757.37 634.07 762.30 630.40 630.18 476.36 432.95 407.36 GP Margin 69.33% 71.22% 69.11% 65.77% 60.38% 66.55% 69.96% 69.41% 64.95% 54.89% 52.28% Total Expenditure 1,203.92 1,157.98 980.18 916.10 961.84 948.32 729.43 693.40 579.39 637.60 617.55 Power & Fuel Cost - 59.24 53.74 52.41 56.79 52.43 40.25 38.76 33.57 28.86 26.30 % Of Sales - 3.85% 4.18% 4.55% 5.41% 4.58% 4.47% 4.27% 4.58% 3.66% 3.38% Employee Cost - 334.88 292.71 281.39 286.39 264.49 235.31 196.59 176.40 149.35 127.87 % Of Sales - 21.76% 22.75% 24.43% 27.27% 23.09% 26.11% 21.65% 24.05% 18.93% 16.41% Manufacturing Exp. - 161.53 122.62 95.70 110.32 120.03 89.12 79.19 61.23 59.96 52.55 % Of Sales - 10.50% 9.53% 8.31% 10.51% 10.48% 9.89% 8.72% 8.35% 7.60% 6.74% General & Admin Exp. - 77.53 59.03 43.99 46.86 71.58 47.71 70.26 27.20 22.50 16.95 % Of Sales - 5.04% 4.59% 3.82% 4.46% 6.25% 5.29% 7.74% 3.71% 2.85% 2.18% Selling & Distn. Exp. - 46.60 26.52 21.42 18.56 29.36 20.79 10.40 6.72 6.37 4.75 % Of Sales - 3.03% 2.06% 1.86% 1.77% 2.56% 2.31% 1.15% 0.92% 0.81% 0.61% Miscellaneous Exp. - 35.34 28.19 26.96 26.89 27.22 25.51 20.48 17.23 14.68 4.75 % Of Sales - 2.30% 2.19% 2.34% 2.56% 2.38% 2.83% 2.26% 2.35% 1.86% 2.22% EBITDA 478.55 380.89 306.25 235.50 88.27 197.20 171.70 214.51 154.00 151.23 161.61 EBITDA Margin 28.44% 24.75% 23.81% 20.45% 8.41% 17.21% 19.05% 23.63% 21.00% 19.17% 20.74% Other Income 7.36 63.65 36.45 17.16 31.41 20.90 40.09 22.23 15.56 32.62 29.34 Interest 52.11 58.79 75.53 91.80 58.65 41.17 21.87 4.56 3.68 2.66 3.13 Depreciation 126.00 119.72 112.99 107.87 95.50 79.80 53.98 43.78 42.06 37.22 30.64 PBT 319.96 266.03 154.18 52.99 -34.47 97.13 135.95 188.40 123.82 143.96 157.17 Tax 46.45 51.98 44.04 22.39 -7.36 41.68 48.85 33.49 26.18 33.91 42.04 Tax Rate 14.52% 18.69% 35.63% 37.87% 21.35% 39.35% 24.82% 17.78% 18.22% 23.56% 27.54% PAT 273.51 243.33 78.29 31.88 -32.48 60.66 147.78 156.15 112.26 105.24 107.57 PAT before Minority Interest 273.51 243.33 78.29 31.96 -30.92 60.58 146.20 154.56 109.50 102.86 104.45 Minority Interest 0.00 0.00 0.00 -0.08 -1.56 0.08 1.58 1.59 2.76 2.38 3.12 PAT Margin 16.26% 15.81% 6.09% 2.77% -3.09% 5.30% 16.40% 17.20% 15.31% 13.34% 13.81% PAT Growth 149.58% 210.81% 145.58% - - -58.95% -5.36% 39.10% 6.67% -2.17% EPS 13.98 12.44 4.00 1.63 -1.66 3.10 7.56 7.98 5.74 5.38 5.50

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 2,713.38 2,646.94 2,142.72 2,117.58 2,065.67 1,637.83 1,453.42 1,281.55 1,156.98 1,029.62 Share Capital 19.56 9.78 8.68 8.68 8.68 8.15 8.15 8.15 8.15 8.01 Total Reserves 2,693.82 2,637.16 2,134.04 2,108.90 2,056.99 1,629.68 1,445.27 1,273.39 1,148.83 1,021.60 Non-Current Liabilities 38.75 65.13 63.27 158.37 210.15 405.58 208.00 157.15 139.08 241.14 Secured Loans 0.00 0.00 0.00 68.00 111.37 324.52 164.48 80.39 67.08 141.18 Unsecured Loans 14.29 14.08 30.02 54.80 8.90 0.00 0.00 0.70 1.03 1.30 Long Term Provisions 5.26 3.98 3.40 0.83 5.83 13.76 8.72 5.36 5.08 5.55 Current Liabilities 276.43 226.24 212.64 242.71 161.65 473.98 359.86 229.59 251.05 219.71 Trade Payables 85.05 40.11 52.69 31.92 23.89 56.91 76.63 71.37 98.86 103.91 Other Current Liabilities 61.97 66.40 33.71 75.39 91.55 164.00 119.85 76.53 56.68 25.20 Short Term Borrowings 115.71 82.43 112.53 125.83 39.56 241.90 156.40 78.72 92.95 88.04 Short Term Provisions 13.70 37.30 13.70 9.57 6.65 11.17 6.97 2.97 2.57 2.55 Total Liabilities 3,028.56 2,938.31 2,418.63 2,518.66 2,437.47 2,517.39 2,021.28 1,668.29 1,547.11 1,490.47 Net Block 638.73 570.18 586.33 608.93 565.78 640.90 517.00 510.84 488.69 448.85 Gross Block 988.50 853.58 827.79 812.42 723.56 918.48 756.00 723.32 666.58 594.31 Accumulated Depreciation 349.77 283.40 241.46 203.48 157.78 277.58 238.99 212.49 177.89 145.46 Non Current Assets 2,502.30 2,483.12 2,041.66 1,882.41 1,692.22 1,737.50 1,113.59 1,147.87 893.90 786.14 Capital Work in Progress 296.95 278.30 228.24 226.43 293.11 482.35 372.81 401.21 200.99 136.51 Non Current Investment 1,222.77 1,235.90 246.45 243.92 237.50 219.32 93.48 89.04 111.35 101.78 Long Term Loans & Adv. 343.78 398.73 980.26 802.92 595.14 391.84 124.54 119.95 68.04 94.26 Other Non Current Assets 0.07 0.01 0.38 0.20 0.69 3.10 5.76 26.83 24.83 4.75 Current Assets 526.26 455.19 376.97 636.25 309.44 779.90 907.69 520.42 653.22 704.32 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 7.89 7.89 119.54 224.62 Inventories 175.03 148.58 111.92 94.50 101.77 299.08 206.23 176.70 167.72 174.96 Sundry Debtors 222.66 176.78 143.82 111.90 102.73 218.27 226.54 181.68 218.14 166.50 Cash & Bank 10.88 4.50 4.46 4.83 15.83 115.27 28.19 90.93 73.14 93.10 Other Current Assets 117.69 53.21 91.20 393.46 89.11 147.28 438.84 63.21 74.67 45.14 Short Term Loans & Adv. 87.76 72.12 25.56 31.57 41.52 106.48 78.47 45.76 58.12 31.39 Net Current Assets 249.83 228.95 164.33 393.54 147.79 305.91 547.83 290.83 402.16 484.62 Total Assets 3,028.56 2,938.31 2,418.63 2,518.66 2,001.66 2,517.40 2,021.28 1,668.29 1,547.12 1,490.46

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 2,591.20 2,362.70 1,808.69 1,783.28 1,822.19 1,478.67 1,329.36 1,197.58 1,085.03 986.90 Share Capital 19.56 9.78 8.68 8.68 8.68 8.15 8.15 8.15 8.15 8.01 Total Reserves 2,571.64 2,352.92 1,800.01 1,774.60 1,813.51 1,470.51 1,321.21 1,189.43 1,076.88 978.88 Non-Current Liabilities 249.46 259.78 589.44 345.12 452.82 561.37 256.94 166.62 153.48 251.26 Secured Loans 183.81 231.96 560.16 242.92 353.49 473.87 164.48 80.39 67.09 141.20 Unsecured Loans 0.00 0.00 0.00 45.90 0.11 0.35 0.53 0.70 1.03 1.30 Long Term Provisions 33.20 25.54 22.43 17.65 19.08 15.48 26.17 21.77 20.32 16.89 Current Liabilities 848.06 674.19 693.59 784.45 611.54 587.46 410.82 253.44 265.84 236.90 Trade Payables 142.47 104.91 174.15 142.80 146.04 76.54 92.55 80.72 103.74 111.86 Other Current Liabilities 252.92 213.19 138.05 276.56 240.13 254.21 142.10 81.62 59.59 28.03 Short Term Borrowings 411.56 306.81 360.73 344.17 202.90 243.40 165.27 86.58 98.12 92.41 Short Term Provisions 41.11 49.28 20.66 20.92 22.46 13.31 10.89 4.52 4.39 4.60 Total Liabilities 3,688.72 3,297.71 3,082.98 2,903.93 2,875.50 2,616.33 1,989.21 1,610.02 1,499.13 1,472.22 Net Block 1,593.12 1,417.84 1,384.86 1,368.33 1,341.84 1,110.53 650.44 558.01 534.20 491.93 Gross Block 2,358.98 2,076.00 1,946.75 1,846.68 1,727.09 1,421.10 986.42 853.16 793.24 704.89 Accumulated Depreciation 765.86 658.16 561.89 478.35 385.25 310.57 335.98 295.15 259.04 212.96 Non Current Assets 2,578.95 2,313.20 2,206.74 2,134.37 1,988.30 1,729.60 1,365.35 1,064.96 827.16 742.33 Capital Work in Progress 884.05 821.77 718.78 655.33 506.18 541.29 666.25 429.12 209.85 140.51 Non Current Investment 57.94 34.54 39.91 42.66 34.23 21.22 10.45 2.25 20.79 27.99 Long Term Loans & Adv. 42.67 37.71 53.32 56.53 93.90 43.10 32.42 48.75 37.47 77.09 Other Non Current Assets 1.17 1.34 9.87 11.52 12.15 13.46 5.78 26.84 24.86 4.80 Current Assets 1,109.77 984.51 876.24 769.55 887.19 862.47 623.85 545.06 671.97 729.88 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 119.54 224.62 Inventories 366.79 347.93 344.93 319.82 355.24 333.19 226.43 187.67 188.71 190.00 Sundry Debtors 518.85 440.79 392.05 324.35 386.33 233.54 246.79 203.73 220.27 170.93 Cash & Bank 45.18 28.57 31.77 21.56 34.11 123.60 44.56 94.54 73.83 100.39 Other Current Assets 178.95 17.59 16.28 15.53 111.52 172.14 106.06 59.13 69.62 43.94 Short Term Loans & Adv. 159.57 149.63 91.22 88.29 102.16 146.24 95.97 47.99 56.59 31.61 Net Current Assets 261.71 310.32 182.65 -14.89 275.66 275.01 213.04 291.62 406.13 492.98 Total Assets 3,688.72 3,297.71 3,082.98 2,903.92 2,875.49 2,592.07 1,989.20 1,610.02 1,499.13 1,472.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 60.00 -19.05 9.55 2.08 173.87 69.63 129.79 164.16 54.46 50.49 PBT 148.13 105.33 38.09 12.68 192.89 255.54 233.99 155.60 167.49 168.53 Adjustment -12.47 5.82 17.13 -35.56 32.64 -25.46 -5.39 25.78 8.68 15.28 Changes in Working Capital -55.06 -112.81 -38.72 33.37 -17.17 -117.10 -57.95 18.23 -81.25 -99.93 Cash after chg. in Working capital 80.60 -1.66 16.50 10.49 208.36 112.97 170.65 199.61 94.92 83.89 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -20.60 -17.39 -6.95 -8.41 -34.49 -43.34 -40.85 -35.45 -40.45 -33.40 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -67.16 -433.25 155.82 -94.83 -378.97 -238.13 -295.10 -214.71 -12.83 -274.78 Net Fixed Assets -153.57 -75.85 -17.18 -22.18 384.16 -272.02 -4.28 -256.96 -136.75 -172.23 Net Investments 13.13 -989.45 -2.53 -6.42 -18.18 -117.95 -4.44 133.96 95.51 -172.72 Others 73.28 632.05 175.53 -66.23 -744.95 151.84 -286.38 -91.71 28.41 70.17 Cash from Financing Activity 13.76 450.09 -163.07 87.68 97.23 255.58 170.10 8.17 -61.16 315.27 Net Cash Inflow / Outflow 6.60 -2.21 2.30 -5.07 -107.88 87.08 4.80 -42.38 -19.53 90.98 Opening Cash & Equivalents 4.76 4.49 2.49 7.42 115.01 27.94 30.53 73.14 92.68 1.70 Closing Cash & Equivalent 10.88 4.50 4.46 2.35 7.13 115.01 27.94 30.76 73.14 92.68

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 342.18 132.27 136.67 179.92 105.13 46.93 124.38 146.78 44.92 37.48 PBT 295.31 122.33 54.34 -38.28 102.26 196.79 188.40 143.70 136.77 146.49 Adjustment 142.45 195.05 221.44 147.81 109.34 4.03 41.32 20.44 18.83 17.19 Changes in Working Capital -35.17 -138.09 -97.92 102.77 -71.99 -106.29 -63.15 18.71 -69.66 -92.61 Cash after chg. in Working capital 402.59 179.29 177.86 212.30 139.62 94.53 166.57 182.85 85.94 71.08 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -60.41 -47.02 -41.19 -32.37 -34.48 -47.60 -42.20 -36.07 -41.02 -33.60 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -325.92 -199.13 -166.58 -232.61 -285.50 -404.28 -289.52 -196.16 -8.76 -262.23 Net Fixed Assets -153.57 -75.85 -17.18 -22.18 384.16 -272.02 -4.28 -256.96 -136.75 -172.23 Net Investments 13.13 -989.45 -2.53 -6.42 -18.18 -117.95 -4.44 133.96 95.51 -172.72 Others -185.48 866.17 -146.87 -204.01 -651.48 -14.31 -280.80 -73.16 32.48 82.72 Cash from Financing Activity 13.62 62.65 46.77 45.80 82.86 436.37 175.50 10.06 -60.91 312.70 Net Cash Inflow / Outflow 29.88 -4.21 16.86 -6.89 -97.51 79.03 10.36 -39.32 -24.75 87.95 Opening Cash & Equivalents 28.57 31.76 19.07 25.62 122.85 44.31 34.13 73.83 99.97 7.05 Closing Cash & Equivalent 45.18 28.57 31.76 19.07 25.34 123.34 44.31 34.36 73.83 99.97

Financial Ratios

Consolidated /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 138.72 135.32 123.43 243.96 237.97 200.89 178.27 157.19 141.91 128.50 ROA 4.46% 2.54% 1.09% -1.83% 0.74% 2.87% 10.50% 7.72% 8.77% 10.53% ROE 4.96% 2.84% 1.26% -2.37% 1.09% 4.21% 14.17% 10.18% 12.19% 15.05% ROCE 5.66% 4.42% 2.36% -1.61% 1.61% 4.67% 14.44% 11.27% 13.00% 16.98% Fixed Asset Turnover 0.65 0.57 0.38 0.32 0.43 0.31 1.09 0.96 1.18 1.39 Receivable days 122.10 122.56 150.65 158.13 164.12 315.80 92.44 109.91 94.36 68.87 Inventory Days 98.92 99.58 121.60 144.60 204.94 358.76 86.71 94.68 84.06 74.10 Payable days 107.78 152.87 194.46 139.04 218.12 479.17 46.77 62.82 63.90 61.73 Cash Conversion Cycle 113.24 69.27 77.79 163.69 150.94 195.39 132.38 141.78 114.52 81.24 Total Debt/Equity 0.05 0.04 0.07 0.14 0.09 0.40 0.26 0.15 0.16 0.23 Interest Cover 15.75 18.94 3.21 -1.80 4.04 15.85 55.05 56.69 79.92 61.31

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 132.47 120.79 104.19 205.44 209.93 181.37 163.06 146.89 133.09 123.17 ROA 6.97% 2.45% 1.07% -1.07% 2.20% 6.33% 8.61% 7.56% 7.41% 9.20% ROE 9.82% 3.75% 1.78% -1.71% 3.67% 10.41% 12.26% 10.30% 10.62% 13.60% ROCE 11.43% 6.95% 5.49% 0.80% 5.94% 10.73% 12.41% 11.05% 11.71% 15.91% Fixed Asset Turnover 0.69 0.64 0.61 0.59 0.73 0.75 0.99 0.89 1.06 1.22 Receivable days 113.81 118.15 113.53 123.51 98.75 94.03 90.56 105.51 90.20 69.00 Inventory Days 84.76 98.29 105.35 117.32 109.68 110.03 83.24 93.66 87.32 75.49 Payable days 101.94 128.16 146.72 126.70 106.00 107.72 47.69 58.00 61.51 60.89 Cash Conversion Cycle 96.62 88.28 72.15 114.12 102.43 96.33 126.11 141.17 116.00 83.61 Total Debt/Equity 0.25 0.25 0.52 0.45 0.37 0.57 0.29 0.16 0.18 0.24 Interest Cover 6.02 2.62 1.59 0.35 3.48 9.92 42.34 40.09 55.10 49.69

Top Investors:

suraj kumar inani

sbi life insurance co. ltd

sunidhi capital private limited

cohesion mk best ideas sub-trust

amal parikh

dovetail india fund class 5 shares

bandhan healthcare fund

elm park fund limited

icici prudential elss tax saver fund

sapphire intrex limited

Annual Reports:

News Update:

Shilpa Medicare - Quarterly Results
6th Aug 2026, 00:00 AM

Read More
Shilpa Medicare’s arm commissions Antibody-Drug Conjugate GMP manufacturing facility
24th Jun 2026, 09:58 AM

This commissioning marks a significant evolution of Shilpa Medicare’s over 25 years of deep-rooted expertise in highly potent compound manufacturing
Read More
Shilpa Medicare’s arm enters into strategic equity partnership with Gate2Brain
3rd Jun 2026, 12:00 PM

G2B-002 delivers SN-38, a potent anticancer agent, across the blood-brain barrier via Gate2Brain's proprietary MiniAp4 peptide shuttle
Read More

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

BSE: 530549 | NSE: SHILPAMED

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: